These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3575832)

  • 1. [131-I-MIBG and sporadic medullary carcinoma of the thyroid].
    Estopiñán V; de Pablos PL; Hurtado A; de la Calle H
    Rev Clin Esp; 1987 Feb; 180(3):174-5. PubMed ID: 3575832
    [No Abstract]   [Full Text] [Related]  

  • 2. 131I-MIBG uptake in a pelvic metastasis of sporadic thyroid medullary cancer.
    Modigliani U; Legnaioli M; Taddei I; Paulin I
    J Nucl Med Allied Sci; 1987; 31(2):223-5. PubMed ID: 3625308
    [No Abstract]   [Full Text] [Related]  

  • 3. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 131I-MIBG by medullary carcinoma of thyroid in familial cases.
    Coutris G; Talbot JN; Kabla G; Calmettes C; Milhaud G
    Eur J Nucl Med; 1986; 12(2):77-9. PubMed ID: 3732310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
    Ahuja S; Koppenhagen K; Ernst H
    Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-MIBG and medullary carcinoma of the thyroid.
    Connell JM; Hilditch TE; Elliott A; Semple PF
    Lancet; 1984 Dec; 2(8414):1273-4. PubMed ID: 6150300
    [No Abstract]   [Full Text] [Related]  

  • 7. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
    Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
    Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
    [No Abstract]   [Full Text] [Related]  

  • 8. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR; Wilf LH
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible use of radioiodinated metaiodobenzylguanidine (MIBG) in medullary thyroid carcinoma.
    Troncone L; Rufini V; Maussier ML; Valenza V; Montemaggi P; Legnaioli M
    Thyroidology; 1988 Apr; (1):45-53. PubMed ID: 2484894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidine.
    Guilloteau D; Baulieu JL; Besnard JC
    Eur J Nucl Med; 1985; 11(6-7):198-200. PubMed ID: 4076227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE; Lazarus CR; Maisey MN
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract]   [Full Text] [Related]  

  • 12. Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma.
    Oishi S; Sasaki M; Sato T; Hirota Y; Takahashi M
    Endocrinol Jpn; 1986 Jun; 33(3):309-15. PubMed ID: 2875869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid uptake of MIBG in Sipple's syndrome.
    Perdrisot R; Rohmer V; Lejeune JJ; Bigorgne JC; Jallet P
    Eur J Nucl Med; 1988; 14(1):37-8. PubMed ID: 2898364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibility of using 131I-meta-iodobenzylguanidine in the diagnosis of neuroendocrine tumors differing from pheochromocytomas].
    Troncone L; Rufini V; Maini CL; Valenza V; Danza FM; Lasorella A
    Radiol Med; 1986 Dec; 72(12):963-8. PubMed ID: 3797720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
    Ansari AN; Siegel ME; DeQuattro V; Gazarian LH
    J Nucl Med; 1986 Dec; 27(12):1858-60. PubMed ID: 2878066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
    Poston GJ; Thomas AM; Macdonald DW; Karvounaris D; Henderson BL; George P; Lynn JA; Lavender JP
    Nucl Med Commun; 1986 Apr; 7(4):215-21. PubMed ID: 2873544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diagnosis of thyroid carcinoma].
    Sandrock D; Munz DL
    Dtsch Med Wochenschr; 1991 Jan; 116(2):77-8. PubMed ID: 1985815
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
    Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN
    J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.